(Q36268305)

13 August 2017

1 reference

title

Stabilisation of calstabin2--a new approach in sudden cardiac death (English)

1 reference

13 August 2017

Sheila A Doggrell

1

1 reference

13 August 2017

language of work or name

English

0 references

publication date

1 October 2005

1 reference

Expert Opinion on Therapeutic Targets

13 August 2017

published in

1 reference

13 August 2017

volume

9

1 reference

13 August 2017

issue

5

1 reference

13 August 2017

page(s)

955-962

1 reference

Altered function and regulation of cardiac ryanodine receptors in cardiac disease

13 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.5.955

Mechanisms of arrhythmogenic delayed and early afterdepolarizations in ferret ventricular muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.5.955

Clinical and molecular characterization of patients with catecholaminergic polymorphic ventricular tachycardia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.5.955

Cellular mechanisms underlying the development of catecholaminergic ventricular tachycardia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.5.955

JTV-519, a novel cardioprotective agent, improves the contractile recovery after ischaemia-reperfusion in coronary perfused guinea-pig ventricular muscles

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.5.955

Protective effect of JTV519, a new 1,4-benzothiazepine derivative, on prolonged myocardial preservation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.5.955

Inhibitory effects of JTV-519, a novel cardioprotective drug, on potassium currents and experimental atrial fibrillation in guinea-pig hearts

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.5.955

Effects of JTV-519, a novel anti-ischaemic drug, on the delayed rectifier K+ current in guinea-pig ventricular myocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.5.955

Protection from cardiac arrhythmia through ryanodine receptor-stabilizing protein calstabin2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.5.955

Clinical implications of cardiac ryanodine receptor/calcium release channel mutations linked to sudden cardiac death

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.5.955

Sudden death in familial polymorphic ventricular tachycardia associated with calcium release channel (ryanodine receptor) leak

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.5.955

Defective cardiac ryanodine receptor regulation during atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.5.955

Protein kinase A phosphorylation of the cardiac calcium release channel (ryanodine receptor) in normal and failing hearts. Role of phosphatases and response to isoproterenol

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.5.955

beta-adrenergic receptor blockers restore cardiac calcium release channel (ryanodine receptor) structure and function in heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.5.955

Valsartan restores sarcoplasmic reticulum function with no appreciable effect on resting cardiac function in pacing-induced heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.5.955

Beta-blockers restore calcium release channel function and improve cardiac muscle performance in human heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.5.955

21 January 2018

Identifiers

DOI

10.1517/14728222.9.5.955

1 reference

13 August 2017

1 reference